MRK vs. MRSH
MRK (Merck & Co., Inc.) and MRSH (Marsh & McLennan Companies, Inc) are both stocks. MRK operates in Drug Manufacturers - General (Healthcare), while MRSH operates in Insurance Brokers (Financial Services). Over the past 10 years, MRK returned 11.59%/yr vs 11.75%/yr for MRSH. At a 0.34 correlation, their price movements are largely independent.
Performance
MRK vs. MRSH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MRK achieves a 13.94% return, which is significantly higher than MRSH's -8.15% return. Both investments have delivered pretty close results over the past 10 years, with MRK having a 11.59% annualized return and MRSH not far ahead at 11.75%.
MRK
- 1D
- -1.42%
- 1M
- 6.89%
- YTD
- 13.94%
- 6M
- 20.60%
- 1Y
- 50.99%
- 3Y*
- 5.87%
- 5Y*
- 12.81%
- 10Y*
- 11.59%
MRSH
- 1D
- 0.32%
- 1M
- 4.74%
- YTD
- -8.15%
- 6M
- -8.49%
- 1Y
- -20.92%
- 3Y*
- -0.08%
- 5Y*
- 5.55%
- 10Y*
- 11.75%
MRK vs. MRSH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
MRK Merck & Co., Inc. | 13.94% | 9.79% | -6.26% | 1.01% | 49.42% | 1.75% | -7.20% | 22.27% | 39.95% | -1.49% |
MRSH Marsh & McLennan Companies, Inc | -8.15% | -11.26% | 13.75% | 16.15% | -3.45% | 50.83% | 6.86% | 42.33% | -0.14% | 22.73% |
Correlation
The correlation between MRK and MRSH is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.15 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.21 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.26 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.32 |
Correlation (All Time) Calculated using the full available price history since Dec 30, 1987 | 0.34 |
The correlation between MRK and MRSH shifts across timeframes, from 0.15 (1 year) to 0.34 (all time), reflecting how their relationship changes across market environments.
Fundamentals
MRK:
$294.29B
MRSH:
$81.98B
MRK:
$3.58
MRSH:
$7.99
MRK:
33.21
MRSH:
21.11
MRK:
0.03
MRSH:
2.46
MRK:
4.52
MRSH:
3.01
MRK:
6.41
MRSH:
5.54
MRK:
$65.59B
MRSH:
$27.52B
MRK:
$49.79B
MRSH:
$11.66B
MRK:
$22.69B
MRSH:
$6.68B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MRK vs. MRSH — Risk / Return Rank
MRK
MRSH
MRK vs. MRSH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Merck & Co., Inc. (MRK) and Marsh & McLennan Companies, Inc (MRSH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MRK | MRSH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.81 | ||
| Sortino ratioReturn per unit of downside risk | +4.01 | ||
| Omega ratioGain probability vs. loss probability | 1.33 | 0.85 | +0.49 |
| Calmar ratioReturn relative to maximum drawdown | 4.49 | -0.80 | +5.29 |
| Martin ratioReturn relative to average drawdown | 11.22 | -1.40 | +12.61 |
Loading charts...
Drawdowns
MRK vs. MRSH - Drawdown Comparison
The maximum MRK drawdown since its inception was -68.61%, roughly equal to the maximum MRSH drawdown of -67.46%. Use the drawdown chart below to compare losses from any high point for MRK and MRSH.
Loading charts...
Drawdown Indicators
| MRK | MRSH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -68.61% | -67.46% | -1.15% |
Max Drawdown (1Y)Largest decline over 1 year | -11.37% | -27.01% | +15.64% |
Max Drawdown (3Y)Largest decline over 3 years | -43.44% | -34.36% | -9.08% |
Max Drawdown (5Y)Largest decline over 5 years | -43.44% | -34.36% | -9.08% |
Max Drawdown (10Y)Largest decline over 10 years | -43.44% | -35.80% | -7.64% |
Current DrawdownCurrent decline from peak | -5.03% | -29.62% | +24.59% |
Average DrawdownAverage peak-to-trough decline | -18.83% | -17.41% | -1.42% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.54% | 15.50% | -10.96% |
Volatility
MRK vs. MRSH - Volatility Comparison
Merck & Co., Inc. (MRK) has a higher volatility of 9.57% compared to Marsh & McLennan Companies, Inc (MRSH) at 6.91%. This indicates that MRK's price experiences larger fluctuations and is considered to be riskier than MRSH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MRK | MRSH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.57% | 6.91% | +2.66% |
Volatility (6M)Calculated over the trailing 6-month period | 18.04% | 19.10% | -1.06% |
Volatility (1Y)Calculated over the trailing 1-year period | 27.18% | 23.47% | +3.71% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 23.66% | 20.20% | +3.46% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.96% | 20.94% | +2.02% |
Dividends
MRK vs. MRSH - Dividend Comparison
MRK's dividend yield for the trailing twelve months is around 2.79%, more than MRSH's 2.13% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MRK Merck & Co., Inc. | 2.79% | 3.12% | 3.14% | 2.72% | 2.52% | 3.41% | 3.03% | 2.48% | 2.60% | 3.36% | 3.14% | 3.43% |
MRSH Marsh & McLennan Companies, Inc | 2.13% | 1.85% | 1.44% | 1.37% | 1.36% | 1.15% | 1.57% | 1.56% | 1.98% | 1.76% | 1.92% | 2.13% |
Financials
MRK vs. MRSH - Financials Comparison
This section allows you to compare key financial metrics between Merck & Co., Inc. and Marsh & McLennan Companies, Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
MRK vs. MRSH - Profitability Comparison
MRK - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Merck & Co., Inc. reported a gross profit of 13.34B and revenue of 16.29B. Therefore, the gross margin over that period was 81.9%.
MRSH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Marsh & McLennan Companies, Inc reported a gross profit of 3.47B and revenue of 7.60B. Therefore, the gross margin over that period was 45.6%.
MRK - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Merck & Co., Inc. reported an operating income of -1.88B and revenue of 16.29B, resulting in an operating margin of -11.6%.
MRSH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Marsh & McLennan Companies, Inc reported an operating income of 1.75B and revenue of 7.60B, resulting in an operating margin of 23.1%.
MRK - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Merck & Co., Inc. reported a net income of -4.24B and revenue of 16.29B, resulting in a net margin of -26.0%.
MRSH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Marsh & McLennan Companies, Inc reported a net income of 1.15B and revenue of 7.60B, resulting in a net margin of 15.1%.
Frequently Asked Questions
MRK and MRSH have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
MRK has higher volatility (9.57%) compared to MRSH (6.91%). In terms of maximum drawdown, MRK dropped -68.61% vs MRSH's -67.46%.
MRK currently has the higher Sharpe Ratio (1.88 vs -0.93), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MRK and MRSH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer